Ankalkoti Basavaraj, Satheesan B, Dipin J, Nizamudheen P, Sangeetha N
1Department of Surgical Oncology, Malabar Cancer Centre, Kodiyeri, Moozhikkara (PO), Thalassery, Kerala 670111 India.
2Department of Pathology, Malabar Cancer Center, Thalassery, Kerala 670111 India.
Indian J Surg Oncol. 2019 Sep;10(3):489-493. doi: 10.1007/s13193-019-00926-5. Epub 2019 May 6.
Giant cell tumor of bone (GCTB) is a rare tumor with a spectrum of clinical behavior. Standard treatment modalities include surgical curettage to wide resection, and varying oncological and functional results have been reported. The aim of this study was to evaluate the functional outcome and recurrence rates of patients who underwent surgery for giant cell tumor in a rural tertiary cancer center from June 2009 to December 2016. A retrospective review of 12 patients (7 males and 5 females) with GCT of the extremity bones treated in the institution between the period of June 2009 and December 2016 was performed to study the oncological and functional outcomes. All patients were evaluated by clinical examination, plain X-ray of local parts, X-ray of the chest, and MRI of local parts. A biopsy was taken in all cases to confirm the diagnosis. All patients underwent surgical treatment including curettage combined with cryosurgery and bone cement or wide resection and reconstruction. Selection of the surgical technique was based on the site and size of the lesion, soft tissue involvement (intra- or extra-compartmental), and if recurrent or not. The patients were followed up to April 2018. The mean age of the patients was 31.3 years. The tumor sites were distal femur in 3 cases, proximal tibia in 6, ischial bone in 1, distal radius in 1, and 1 in the metacarpal bone. Campanacci radiographic grading was grade1 in 3 cases, grade 2 in 2 cases, and grade 3 in 7 cases. Out of 12 patients, local recurrence was noted in 2 patients (16.7%). Functional evaluation was performed according to the Musculoskeletal Tumor Society Scoring (MSTS) system. Mean MSTS score was 25. To preserve the good function of the extremities and avoid local recurrence, we consider that curettage with adjunctive therapy such as polymethylmethacrylate (PMMA) and liquid nitrogen should be employed for the treatment of benign GCT of bone. Wide excision should be considered for large tumors where achieving oncological results with functional preservation would be difficult with curettage procedure.
骨巨细胞瘤(GCTB)是一种临床行为多样的罕见肿瘤。标准治疗方式包括从刮除术到广泛切除术,且已报道了不同的肿瘤学和功能学结果。本研究的目的是评估2009年6月至2016年12月期间在一家农村三级癌症中心接受骨巨细胞瘤手术患者的功能结局和复发率。对该机构在2009年6月至2016年期间治疗的12例(7例男性和5例女性)四肢骨巨细胞瘤患者进行回顾性研究,以探讨肿瘤学和功能学结局。所有患者均通过临床检查、局部平片、胸部X线和局部MRI进行评估。所有病例均进行活检以确诊。所有患者均接受手术治疗,包括刮除术联合冷冻手术和骨水泥或广泛切除及重建。手术技术的选择基于病变的部位和大小、软组织受累情况(间室内或间室外)以及是否复发。对患者随访至2018年4月。患者的平均年龄为31.3岁。肿瘤部位:3例位于股骨远端,6例位于胫骨近端,1例位于坐骨,1例位于桡骨远端,1例位于掌骨。坎帕纳奇放射学分级:3例为1级,2例为2级,7例为3级。1个2例患者(16.7%)出现局部复发。根据肌肉骨骼肿瘤学会评分(MSTS)系统进行功能评估。MSTS平均评分为25分。为保留肢体的良好功能并避免局部复发,我们认为对于骨良性巨细胞瘤的治疗应采用刮除术并辅以聚甲基丙烯酸甲酯(PMMA)和液氮等治疗。对于大型肿瘤,如果刮除术难以在保留功能的同时达到肿瘤学效果,则应考虑广泛切除。